The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.